0% found this document useful (0 votes)
9 views2 pages

Anti-Inflammatory Drug Guidelines

Pharmacology general information about Anti-inflammatory drugs

Uploaded by

arlando lulu
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
9 views2 pages

Anti-Inflammatory Drug Guidelines

Pharmacology general information about Anti-inflammatory drugs

Uploaded by

arlando lulu
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

REINHOLD SCRIPT

1. ANTI-INFLAMMATORY DRUGS
a. NSAIDS
i. General
- Assess for history of gastrointestinal disorders (e.g., peptic ulcers, GI bleeding)
- Rationale: NSAIDs can cause gastrointestinal irritation and increase the
risk of bleeding or ulceration.
- Monitor for signs of bleeding (e.g., tarry stools, bruising, hematemesis)
- Rationale: NSAIDs inhibit platelet aggregation, increasing the risk of
bleeding.
ii. Aspirin
- If administering aspirin, monitor for signs of aspirin toxicity (e.g., tinnitus,
dizziness).
- Rationale: Aspirin can cause ototoxicity and toxicity at higher doses.
iii. Diclofenac and Ibuprofen
- Administer slowly as per protocol (e.g., ibuprofen infusion over 30 minutes)
- Rationale: Rapid administration of NSAIDs intravenously can cause
serious adverse effects, including hypotension or renal toxicity.
b. Corticosteroids
i. General
- Monitor vital signs, especially blood pressure and temperature
- Rationale: Corticosteroids can cause fluid retention and hypertension, and
mask signs of infection.
- Assess for signs of infection
- Rationale: Corticosteroids suppress the immune system, increasing the
risk of infections.
- Educate the patient on the importance of tapering the dose gradually, especially
with long-term use
- Rationale: Abrupt cessation can lead to adrenal insufficiency, which can
be life-threatening.
ii. hydrocortisone
- Monitor for skin reactions (e.g., thinning of the skin, striae, or discoloration)
- Rationale: Long-term topical corticosteroids can cause skin atrophy and
other local skin effects.
c. Anti-Gout
i. General
- Assess baseline uric acid levels and monitor them regularly
- Rationale: Monitoring helps evaluate the drug's effectiveness in reducing
uric acid levels.
- Encourage increased fluid intake (2-3 liters/day)
- Rationale: This helps prevent uric acid crystal formation and promotes
kidney function to reduce the risk of kidney stones.
- Monitor for gastrointestinal discomfort
- Rationale: Oral administration of these drugs can cause GI side effects
like nausea, vomiting, or diarrhea.
- Encourage adherence to a consistent dosing schedule
- Rationale: To maintain therapeutic drug levels and prevent gout flare-ups.
- Ensure the patient takes the medication with a full glass of water
- Rationale: This helps with drug absorption and prevents kidney
complications.

Common questions

Powered by AI

Long-term use of topical corticosteroids like hydrocortisone can cause skin atrophy, which includes thinning of the skin, formation of striae, or discoloration. Monitoring for these skin reactions is essential to manage and prevent these adverse effects. Patients should be advised regarding the potential for these side effects and monitored regularly, especially if they are using these medications over extended periods .

Aspirin toxicity should be monitored by observing for early signs such as tinnitus and dizziness. These symptoms indicate ototoxicity and potential overdose. It is essential to be vigilant in patients receiving aspirin, especially at higher doses, to prevent serious complications .

Corticosteroids can affect vital signs by causing fluid retention and hypertension, which necessitates regular monitoring of blood pressure and temperature. They can also mask signs of infection due to their immunosuppressive effects, increasing the risk of infections. Health care providers should assess patients for signs of infection and educate them on gradually tapering off corticosteroids to avoid adrenal insufficiency, which can be life-threatening .

NSAIDs contribute to increased bleeding risk by inhibiting platelet aggregation, which is crucial for blood clot formation. This mechanism disrupts the normal protective actions on the gastric mucosa, increasing the risk for GI bleeding. To reduce this risk, healthcare providers should screen for pre-existing gastrointestinal disorders, monitor for bleeding signs like tarry stools or bruising, and instruct patients on the correct usage of NSAIDs. Careful dosing and co-administration with gastroprotective agents may also be considered based on individual risk assessments .

Abrupt cessation of corticosteroid therapy can lead to adrenal insufficiency, a potentially life-threatening condition. To avoid these risks, it is essential to taper the corticosteroid dosage gradually, according to a specific schedule tailored to the patient's needs. Health care providers should educate patients on the importance of tapering and closely monitor them during the process to prevent withdrawal symptoms and ensure safe discontinuation .

Monitoring uric acid levels plays a crucial role in anti-gout therapies as it helps evaluate the effectiveness of the drug in reducing uric acid levels, thus managing gout. Regular monitoring ensures that the levels remain within a target range to prevent flare-ups. Patient adherence to a consistent dosing schedule is critical to maintain therapeutic drug levels and effectively prevent gout attacks .

When administering diclofenac and ibuprofen intravenously, it is important to follow specific protocols like infusing ibuprofen over 30 minutes. These precautions are necessary because rapid administration can cause serious adverse effects, including hypotension and renal toxicity. Careful adherence to administration guidelines ensures patient safety and minimizes the risk of such complications .

NSAIDs can cause gastrointestinal irritation and increase the risk of bleeding or ulceration due to their mechanism of action, which involves the inhibition of prostaglandin synthesis that protects the GI tract. To mitigate these risks, it is important to assess for a history of gastrointestinal disorders such as peptic ulcers or GI bleeding. Monitoring for signs of bleeding, such as tarry stools, bruising, or hematemesis, is also crucial because NSAIDs inhibit platelet aggregation, increasing the risk of bleeding .

Maintaining an increased fluid intake, typically between 2-3 liters per day, is recommended for patients undergoing anti-gout treatment because it helps prevent uric acid crystal formation. This practice promotes kidney function and reduces the risk of kidney stones, thereby enhancing the efficacy of anti-gout medications and minimizing the potential for complications .

Oral anti-gout medications can cause gastrointestinal side effects such as nausea, vomiting, or diarrhea. To manage these effects, monitoring for and addressing symptoms promptly is important. Encouraging patients to take medications with a full glass of water can also help with drug absorption and mitigate some of the gastrointestinal discomfort .

You might also like